StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Zomedica's shares outstanding was 980M at Jun 30, 2026. For fiscal 2025 it was 980M, up 0.0% from the year before. The highest annual figure on record is 980M in fiscal 2022.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025980M0.0%
FY2024Dec 31, 2024980M0.0%
FY2023Dec 31, 2023980M0.0%
FY2022Dec 31, 2022980M+2.4%
FY2021Dec 31, 2021957M+162.5%
FY2020Dec 31, 2020364M+242.9%
FY2019Dec 31, 2019106M+13.8%
FY2018Dec 31, 201893M+6.9%
FY2017Dec 31, 201787M+9.0%
FY2016Dec 31, 201680M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026980M0.0%
Q1 FY2026Mar 31, 2026980M0.0%
Q4 FY2025Dec 31, 2025980M0.0%
Q3 FY2025Sep 30, 2025980M0.0%
Q2 FY2025Jun 30, 2025980M0.0%
Q1 FY2025Mar 31, 2025980M0.0%
Q4 FY2024Dec 31, 2024980M0.0%
Q3 FY2024Sep 30, 2024980M0.0%
Q2 FY2024Jun 30, 2024980M0.0%
Q1 FY2024Mar 31, 2024980M0.0%
Q4 FY2023Dec 31, 2023980M0.0%
Q3 FY2023Sep 30, 2023980M0.0%
Q2 FY2023Jun 30, 2023980M+0.0%
Q1 FY2023Mar 31, 2023980M+0.0%
Q4 FY2022Dec 31, 2022980M-0.0%
Q3 FY2022Sep 30, 2022980M+0.1%
Q2 FY2022Jun 30, 2022980M+0.6%
Q1 FY2022Mar 31, 2022980M+10.1%
Q4 FY2021Dec 31, 2021980M+67.9%
Q3 FY2021Sep 30, 2021978M+77.7%
Q2 FY2021Jun 30, 2021974M+353.2%
Q1 FY2021Mar 31, 2021890M+652.3%
Q4 FY2020Dec 31, 2020584M+440.3%
Q3 FY2020Sep 30, 2020551M+409.6%
Q2 FY2020Jun 30, 2020215M+98.8%
Q1 FY2020Mar 31, 2020118M+17.3%
Q4 FY2019Dec 31, 2019108M+12.4%
Q3 FY2019Sep 30, 2019108M+14.3%
Q2 FY2019Jun 30, 2019108M+16.8%
Q1 FY2019Mar 31, 2019101M+11.4%
Q4 FY2018Dec 31, 201896M+7.5%
Q3 FY2018Sep 30, 201895M+6.4%
Q2 FY2018Jun 30, 201893M+6.3%
Q1 FY2018Mar 31, 201891M+7.2%
Q4 FY2017Dec 31, 201789M–
Q3 FY2017Sep 30, 201789M–
Q2 FY2017Jun 30, 201787M–
Q1 FY2017Mar 31, 201784M–

More Zomedica figures

See a number that looks wrong?